Brecon Pharmaceuticals

Kay O’Hagan has been appointed director of quality assurance and regulatory affairs at Brecon Pharmaceuticals. Ms O’Hagan will be responsible for Brecon’s QA and regulatory activities and will head the company’s team of Qualified Persons.

Ms O’Hagan joins the company from a major pharmaceutical company, where she was head of quality assurance in the UK. Ms. O’ Hagan is a microbiologist by training and has a wealth of knowledge and experience in R&D, production, quality control and quality assurance.

“We are pleased to welcome Kay on board,” said managing director Peter Belden. “Experience of the sort she is able to demonstrate is vital to the future growth of the company and we wish her every success in her new role.”